Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Department of Medicine

Dataset

1 Article

2 results

Filter

2021
12 Citations (Scopus)
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
14 Jan 2021, In: Clinical Epigenetics. 13, 1, 9.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
12 Citations (Scopus)